Viewing Study NCT06616350


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2025-12-27 @ 11:11 PM
Study NCT ID: NCT06616350
Status: COMPLETED
Last Update Posted: 2024-09-27
First Post: 2024-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Impact of EsTOCma on OCD Family Members
Sponsor: University of Valencia
Organization:

Study Overview

Official Title: Impact of EsTOCma on OCD Family Members
Status: COMPLETED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: esTOCma family
Brief Summary: The goal of this clinical trial is to test the acceptability, feasibility, and effectiveness of esTOCma in families and relatives of individuals with obsessive-compulsive disorder (OCD).

Specifically, a randomized controlled trial with two conditions (experimental and control) has been carried out in a sample of families and relatives of individuals with obsessive-compulsive disorder to assess pre-post-intervention changes. Researchers will compare experimental and control group to see if after using the app there is: lower stigma, higher knowledge and understanding about OCD, higher intention to seek help, and higher self-esteem and lower obsessive-compulsive symptoms. and there are no changes in the control group.

The experimental group received the intervention through the esTOCma app.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: